Liver transplantation for sclerosing cholangitis
Shunji Narumi, John P. Roberts, Jean C. Emond, John Lake, Nancy L. Ascher – 1 August 1995 – The clinical course of 37 patients who underwent 46 liver transplantations for primary (n = 33) and secondary (n = 4) sclerosing cholangitis was reviewed. The median follow‐up was 37 months. The patient and graft survivals for patients with primary sclerosing cholangitis at 1, 2, and 5 years were 96.9%, 91.6%, 87.9%, and 83.1%, 74.2%, 65.2%, respectively.